Sign in
4

Changes in Ownership

AN2 Therapeutics, Inc. Filed Acc 0001415889-24-021199

10% owner sold 3,525,094 shares at $1.08 ($3,807,102)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2024-08-09 Sale −3,410,335 $1.08 $3,683,162 1,725,348 I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2024-08-09 Sale −114,759 $1.08 $123,940 300,853 I
Open-market sales · 3,525,094 sh · avg $1.08 · $3,807,102
Loading xslF345X05/form4-08132024_090830.xml…